ATRX and neoplasm: These events are followed by frequent mutations in ATRX/TP53 (in 1p19q intact tumors) or FUBP1/CIC (in 1p19q co-deleted tumors), which affect different tumor cell sub-clones, reflecting on the concept that clonal evolution of tumors occurs in both space and time [23].